Company Monitoring Page for AbbVie

latest headlines for company on cafepharma

Up-and-coming Pfizer, AbbVie drugs set to threaten Amgen, Celgene: analyst
Fierce Pharma
Wed, 05/23/18 - 09:54 am
Tags:
Pfizer, Xeljanz, AbbVie, Upadacitinib, JAK inhibitors, Amgen, Enbrel, Celgene
FDA Clears IND for CytomX's CX-2029, a CD71-Directed Probody Therapeutic
CP Wire
Tue, 05/22/18 - 09:53 am
Tags:
CytomX, AbbVie, CX-2029, cancer
Tue, 05/22/18 - 08:41 am
Tags:
CytomX, AbbVie, CX-2029
Amgen, AbbVie 'ahead of the crowd' in fighting payers' latest assault on copay coupons
Fierce Pharma
Mon, 05/21/18 - 09:18 am
Tags:
copay coupons, Amgen, AbbVie, payers
AbbVie bows to pressure to keep cheaper Imbruvica formula on the market
Fierce Pharma
Wed, 05/16/18 - 06:57 pm
Tags:
AbbVie, Imbruvica
AbbVie's elagolix could put pressure on budgets, ICER estimates
Biopharma Dive
Tue, 05/8/18 - 03:46 pm
Tags:
AbbVie, endometriosis, ICER, Elagolix
21% Of AbbVie Inc (ABBV) Shareholders Want To Know How Drug Pricing Is Integrated Into Incentive Programs
Value Walk
Sat, 05/5/18 - 11:15 am
Tags:
AbbVie, executive pay, shareholders
Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands
Fierce Pharma
Wed, 05/2/18 - 09:52 am
Tags:
AbbVie, Pfizer, television ads, DTC ads, Humira, Lyrica
AbbVie Submits Marketing Application to the European Medicines Agency for Risankizumab in Plaque Psoriasis
CP Wire
Tue, 05/1/18 - 09:25 pm
Tags:
AbbVie, EMA, Europe, risankizumab, psoriasis
Tue, 05/1/18 - 10:08 am
Tags:
AbbVie, psoriasis, risankizumab
AbbVie's First Quarter: Trying to Replace Humira Sales
Yahoo/Motley Fool
Sun, 04/29/18 - 12:20 pm
Tags:
AbbVie, earnings, Humira
The hepatitis C duopoly
Axios
Fri, 04/27/18 - 10:26 pm
Tags:
AbbVie, hepatitis C, Gilead Sciences
AbbVie shares rise 3% on Q1 profit, revenue beats and $7.5 billion share buyback
Marketwatch
Thu, 04/26/18 - 10:06 am
Tags:
AbbVie, earnings
AbbVie's Upadacitinib Meets Primary and Key Efficacy Endpoints in Phase 2b/3 Rheumatoid Arthritis Study
CP Wire
Wed, 04/25/18 - 11:16 am
Tags:
AbbVie, rheumatoid arthritis, Upadacitinib, clinical trials
This Small Biotech Is Building on a Surprising Success
Motley Fool
Wed, 04/25/18 - 09:32 am
Tags:
AbbVie, Mavyret, Enanta Pharmaceuticals, glecaprevir, hepatitis C
Immunotherapies, biosimilars to dominate next week of earnings
Biopharma Dive
Tue, 04/24/18 - 10:50 pm
Tags:
AbbVie, AstraZeneca, Bristol-Myers Squibb, Celgene, Roche, Vertex Pharmaceuticals, Sanofi, earnings
Fujifilm Kyowa Kirin Biologics Partners with Mylan to Commercialize Biosimilar to Humira in Europe
CP Wire
Wed, 04/11/18 - 11:05 am
Tags:
Humira, Mylan, Fujifilm, AbbVie, biosimilars, FKB327
With study success, AbbVie's arthritis hopeful looks to be a safer bet
Biopharma Dive
Wed, 04/11/18 - 09:18 am
Tags:
AbbVie, rheumatoid arthritis, Upadacitinib, Humira, clinical trials
Tue, 04/10/18 - 04:36 pm
Tags:
FDA Requires More Time to Review Abbvie and Neurocrine Endometriosis Drug Elagolix
CP Wire
Tue, 04/10/18 - 09:30 am
Tags:
AbbVie, Neurocrine, FDA, Elagolix, endometriosis

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.